Your fact-checks will appear here
Company in Eden Prairie, United States
Optum is the healthcare services arm of UnitedHealth Group, formed in 2011 and now a vast business spanning pharmacy, analytics and direct care; UnitedHealth/Optum have completed multibillion-dollar d...
Available reporting and product pages indicate Neurocept is marketed primarily through its own “official” websites and third‑party review/affiliate pages; multiple sources state it is “exclusively” or...
designated 14 Medicaid service types as “” and launched a third‑party pre‑payment audit after finding programmatic vulnerabilities, evidence of , and data‑analytics flags such as suspicious patterns, ...
UnitedHealth Group is a publicly traded corporation whose shares are widely held by institutional investors (about 80%–81% per market-data sites) with a small portion held by company insiders and reta...
Federal and state regulators have opened multiple probes and lawsuits touching Optum’s national footprint: the U.S. Department of Justice launched an antitrust investigation into UnitedHealth/Optum’s ...
Optum significantly grew in New Jersey over the last decade largely through acquisitions and an expanding clinic network—most notably buying Riverside Medical Group in 2022 and rebranding/operating do...
Available reporting does not provide a single, definitive percentage of New Jersey hospitals and physician practices that are employed by Optum; sources do report that Optum operates "more than 360 cl...
Ivermectin dosing for approved parasitic conditions is weight‑based and typically in the 150–200 micrograms per kilogram (mcg/kg) range as a single oral dose, with repeat dosing for some infections an...
Ivermectin can interact with many prescription drugs and with alcohol, raising risks such as increased central nervous system (CNS) depression, altered blood levels of co‑administered drugs, and bleed...
Ivermectin has been reported to , raising the risk of elevated INR and bleeding; multiple drug-information pages, case reports, and clinical summaries advise closer INR monitoring and possible dose ad...